Fatty acids, eicosanoids, and hypolipidemic agents regulate gene expression through direct binding to peroxisome proliferator-activated receptors

Advances in Experimental Medicine and Biology

Volumn 447, Issue , 1999, Pages 199-209

  Wahli, Walter ^a   Devchand, Pallavi R ^a   IJpenberg, Annemieke ^a   Desvergne, Béatrice ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CELL NUCLEUS RECEPTOR; FATTY ACID; ICOSANOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;

CONFERENCE PAPER; ENERGY BALANCE; ENERGY EXPENDITURE; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; IMMUNOMODULATION; LIGAND BINDING; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0033278397     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4861-4_19     Document Type: Conference Paper

References (40)

1. Adams M, Reginato MJ, Shoa D, Lazar MA and Chatterjee VK. (1997) Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site, J. Biol. Chem. 272, 5128-5132.
2. Braissant O, Foufelle F, Scotto C, Dauça M and Wahli W. (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR alpha, beta and gamma in the adult rat, Endocrinology 137, 354-366.
3. Brock TG, McNish RW, Bailie MB and Peters-Golden M. (1997) Rapid import of cytosolic 5-lipoxygenase into the nucleus of neutrophils after in vivo recruitment and in vitro adherence, J. Biol. Chem. 272, 8276-8280.
4. Brun RP, Kim JB, Hu E, Altiok S and Spiegelman BM. (1996a) Adipocyte differentiation: a transcriptional regulatory cascade, Current Opinion in Cell Biology 8, 826-832.
5. Brun RP, Tontonoz P, Forman BM, Ellis R, Chen J, Evans RM and Spiegelman BM. (1996b) Differential activation of adipogenesis by multiple PPAR isoforms, Genes Dev. 10, 974-984.
6. Camp HS and Tafuri SR. (1996) Regulation of peroxisome proliferator-activated receptor γ activity by mitogen- activated protein kinase, J. Biol. Chem. 272, 10811-10816.
7. Canan Koch SS, Dardashti LJ, Hebert JJ, White SK, Croston GEF, Flatten KS, Heyman RA, and Nadzan AM. (1996) Identification of the First Retinoid X Receptor Homodimer Antagonist, J. Med. Chem. 39, 3229-3234.
8. Desvergne B and Wahli W. (1995) PPAR: a key nuclear factor in nutrient/gene interaction? In: Inducible gene expression, PA Baeuerle ed, Birkhäuser, Boston, Vol 1, pp. 142-176.
9. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ and Wahli W (1996) The PPARα-leukotriene B4 pathway to inflammation control, Nature 384, 39-43.
10. Devchand PR and Wahli W, (1997) PPARα: Tempting fate with fat, In: Hormones and Signalling BW O'Malley ed, Academic Press, San Diego, Vol 1 in press.
11. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G and Wahli W. (1992) Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors, Cell 68, 879-87.
12. Dowell P, Peterson VJ, Zabriskie TM and Leid M. (1997) Ligand-induced peroxisome proliferator-activated receptor α conformational change, J. Biol. Chem. 272, 2013-2020.
13. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM and Evans RM. (1995) 15-deoxy-delta(12,14)-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR-gamma, Cell 83, 803-12.
14. Forman BM, Chen J and Evans RM. (1997) Hypolipidemic drugs, polyunsaturated fatty acids and eicosanoids are ligands for PPARα and PPARγ, Proc. Natl. Acad. Sci. USA 94, 4312-4317.
15. Gearing KL, Göttlicher M, Teboul M, Widmark E and Gustafsson JÅ. (1993) Interaction of the peroxisome proliferator-activated receptor and retinoid X receptor, Proc. Natl. Acad. Sci. USA 90, 1440-1444.
16. Göttlicher M, Widmark E, Li Q and Gustafsson JÅ. (1992) Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor, Proc. Natl. Acad. Sci. USA 89, 4653-4657.
17. Hu ED, Tontonoz P and Spiegelman BM. (1995) Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR-gamma and C/EBP-alpha, Proc. Natl. Acad. Sci. USA 92, 9856-9860.
18. Hu E, Kim JB, Sarraf P and Spiegelman BM. (1996) Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ, Science 274, 2100-2103.
19. Issemann I and Green S. (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators, Nature 347, 645-650.
20. Upenberg A, Jeannin E, Wahli W and Desvergne B. (1997) Polarity and specific sequence requirements of PPAR- RXR heterodimer binding to DNA: A functional analysis of the malic enzyme gene PPRE, J. Biol. Chem., 272, 20108-20117.
21. Juge-Aubry C, Pernin A, Favez T, Burger AG, Wahli, W, Meier CA and Desvergne B. (1998) DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements: importance of the 5′ flanking region, J. Biol. Chem.. 272, 25252-25259.
22. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K and Wahli W. (1993) Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers, Proc. Natl. Acad. Sci. USA 90, 2160-2164.
23. Keller H, Devchand PR, Perroud M and Wahli W. (1997) PPARα structure-function relationships derived from species-specific differences in responsiveness to hypolipidemic agents, Biol. Chem., 378, 651-655.
24. Kliewer SA, Umesono K, Noonan DJ, Heyman RA and Evans RM. (1992) Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors, Nature 358, 771-774.
25. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC and Lehmann JM. (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation, Cell 83, 813-819.
26. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS Devchand P, Wahli W, Willson TM, Lenhard JM and Lehmann JM. (1997) Fatty acids and eicosanoids regulate gene expression through direct in teractions with peroxisome proliferator-activated receptors α and γ, Proc. Natl. Acad. Sci. USA 94, 4318-4323.
27. Krey G, Braissant O, L'Horset F, Kalkhoven E, Perroud M, Parker MG and Wahli, W. (1997) Fatty acids, eicosanoids and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by CARLA, Mol. Endocrinol. 11, 779-791.
28. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H and Gonzalez FJ. (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators, Mol. Cell Biol. 15, 3012-3022.
29. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM and Kliewer SA. (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma), J. Biol. Chem. 270, 12953-12956.
30. Lemberger T, Desvergne B and Wahli W. (1996a). Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology, Annu. Rev. Cell Dev. Biol. 12, 335-363.
31. Lemberger T, Saladin R, Vazquez M, Assimacopoulos F, Staels B, Desvergne B, Wahli W and Auwerx J. (1996b) Expression of the peroxisome proliferator-activated receptor alpha gene is stimulated by stress and follows a diurnal rhythm, J. Biol. Chem. 271, 1764-1769.
32. Lemberger T, Staels B, Saladin R, Desvergne B, Auwerx J and Wahli W. (1994) Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids, J. Biol. Chem. 269, 24527-24530.
33. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM and Kliewer SA. (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma), J. Biol. Chem. 270, 12953-12956.
34. Mukherjee R, Davies PJA, Crombie DL, Bischoff ED, Cesarie RM, Jow L, Hamann LG, Boehm MF, Mondon CE, Nadzan AM, Paterniti JR Jr, and Heyman RA. (1997) Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists, Nature 386, 407-410.
35. Schulman IG, Li C, Schwabe JWR and Evans RM. (1997) The phantom ligand effect: allosteric control of transcription by the retinoid X receptor, Genes Dev. 11, 299-308.
36. Serhan C. (1996) Signalling the fat controller, Nature 384, 23-24.
37. Shalev A, Siegrist-Kaiser CA, Yen PM, Wahli W, Burger AG, Chin WW and Meier CA. (1996) The peroxisome proliferator-activated receptor a is a phosphoprotein: regulation by insulin, Endocrinology 137, 4499-4502.
38. Tontonoz P, Hu E, Graves RA, Budavari AI and Spiegelman BM. (1994) mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer, Genes Dev. 8, 1224-1234.
39. Vidal-Puig AJ, Considine RV, Jimenez-Linan M, Werman A, Pories WJ, Caro JF and Flier JS. (1997) Peroxisome proliferator-activated receptor gene expression in human tissues, J. Clin. Invest. 99, 2416-2422.
40. Willson TM and Wahli W. (1997) Peroxisome Proliferator-Activated Receptor (PPAR) agonists, Current Opinion in Chemical Biology, 1, 235-241.